MediciNova Inc 4875.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
569.00quote price arrow down-11.00 (-1.90%)
Volume
60,700
52 week range
267.00 - 923.00

...

Loading . . .

KEY STATS

  • Open570.00
  • Day High575.00
  • Day Low556.00
  • Prev Close580.00
  • 52 Week High923.00
  • 52 Week High Date07/28/20
  • 52 Week Low267.00
  • 52 Week Low Date03/12/20
  • Market Cap251.24M
  • Shares Out45.02M
  • 10 Day Average Volume92,390
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change26.73

RATIOS/PROFITABILITY

  • EPS (TTM)-368.30
  • P/E (TTM)-1.54
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest MediciNova Inc News

There is no recent news for this security.

Latest 4875.T-JP News From Our Partners

QUOTE FINDER

Profile

MORE
Medicinova, Inc. is a biopharmaceutical company. The company is focused on developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs. The Company is developing activities on MN-166 (ibudilast) for neurological disorders, such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction...
Jeffrey Himawan Ph.D.
Chairman
Yuichi Iwaki M.D. Ph.D.
President
Edward Stepanow
Chief Financial Officer
Geoffrey O'brien J.D.
Vice President
Address
4275 Executive Sq Ste 300
La Jolla, CA
92037-8408
United States